Altfest L J & Co. Inc. Sells 5,124 Shares of Danaher Corporation $DHR

Altfest L J & Co. Inc. lessened its stake in Danaher Corporation (NYSE:DHR) by 47.4% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 5,680 shares of the conglomerate’s stock after selling 5,124 shares during the period. Altfest L J & Co. Inc.’s holdings in Danaher were worth $1,126,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. WFA of San Diego LLC bought a new position in shares of Danaher during the 2nd quarter worth about $26,000. Howard Hughes Medical Institute acquired a new stake in shares of Danaher in the 2nd quarter worth about $27,000. Tripletail Wealth Management LLC bought a new position in Danaher in the 3rd quarter valued at about $31,000. Red Tortoise LLC boosted its stake in Danaher by 175.0% during the 2nd quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock valued at $30,000 after purchasing an additional 98 shares during the last quarter. Finally, Heartwood Wealth Advisors LLC bought a new stake in Danaher during the 3rd quarter worth approximately $37,000. 79.05% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on the company. TD Cowen lifted their target price on Danaher from $250.00 to $260.00 and gave the company a “buy” rating in a research report on Wednesday, October 22nd. Redburn Partners set a $220.00 price target on shares of Danaher in a research report on Wednesday, October 8th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Danaher in a research report on Monday. HSBC lifted their target price on shares of Danaher from $255.00 to $270.00 and gave the stock a “buy” rating in a research report on Monday, December 1st. Finally, Rothschild Redb lowered Danaher from a “strong-buy” rating to a “hold” rating in a report on Wednesday, October 8th. Twenty-one investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $248.25.

Danaher Stock Performance

NYSE:DHR opened at $230.42 on Friday. The company has a market capitalization of $162.76 billion, a P/E ratio of 47.51, a P/E/G ratio of 4.07 and a beta of 0.89. The business has a fifty day simple moving average of $223.80 and a two-hundred day simple moving average of $209.10. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.52 and a quick ratio of 1.10. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $258.23.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Monday, October 20th. The conglomerate reported $1.89 earnings per share for the quarter, topping the consensus estimate of $1.72 by $0.17. Danaher had a return on equity of 10.92% and a net margin of 14.44%.The company had revenue of $6.05 billion during the quarter, compared to the consensus estimate of $6 billion. During the same quarter in the prior year, the company earned $1.71 EPS. The firm’s quarterly revenue was up 4.4% compared to the same quarter last year. On average, analysts expect that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Friday, December 26th will be paid a $0.32 dividend. The ex-dividend date is Friday, December 26th. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. Danaher’s dividend payout ratio (DPR) is presently 26.39%.

Insider Activity

In other Danaher news, Director Teri List sold 3,298 shares of the business’s stock in a transaction on Tuesday, November 18th. The shares were sold at an average price of $226.50, for a total transaction of $746,997.00. Following the sale, the director owned 20,762 shares of the company’s stock, valued at $4,702,593. The trade was a 13.71% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, SVP Georgeann Couchara sold 5,174 shares of the stock in a transaction on Monday, November 10th. The stock was sold at an average price of $210.42, for a total value of $1,088,713.08. Following the sale, the senior vice president owned 2,625 shares in the company, valued at approximately $552,352.50. This represents a 66.34% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 30,248 shares of company stock valued at $6,609,663 over the last quarter. Company insiders own 11.10% of the company’s stock.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.